Zoundream raises €4 million in seed funding to enhance its AI-driven neonatal care solutions, already integrated into leading baby monitors and backed by prominent partnerships.

Target Information

Zoundream, founded in Basel by Roberto Iannone, Matteo Ingravalle, and Ana Laguna Pradas, is at the forefront of neonatal care innovation. The company specializes in the development of artificial intelligence-based tools designed for the analysis of infant vocalizations. By interpreting newborn cries and sounds in real-time, Zoundream's technology provides critical insights into an infant's needs, as well as the ability to identify early signs of health issues, including gastrointestinal disturbances and atypical neurodevelopment.

Currently, Zoundream's technology is already integrated into top market baby monitors offered by leading global brands, including Philips Avent, Maxi-Cosi, and Motorola Nursery. The company's collaborations extend to esteemed European institutions such as Hospital Clínic Barcelona, University Medical Center Utrecht, and the University Children’s Hospital Zurich, facilitating the incorporation of its innovative system into clinical practice.

Industry Overview

The neonatal care industry in Switzerland is recognized for its commitment to advanced healthcare technologies and innovative medical solutions. Switzerland's healthcare system is characterized by its high standards, emphasis on res